Cellular localization (colon cancer cells) and competitive binding studies showed that conjugates 59 and 60 with LARLLT peptide showed specific binding with the epidermal growth factor receptor (EGFR) protein, compared with the conjugates 61 and 62, not containing peptide. This evidence concerns the gene EGFR and colonic neoplasm.